// App-Quantinova.ai

: Blood Eosinophil Counts in Patients with Marked FEV1 Reversibility and Fixed Airflow Obstruction

Researchers

Presenter

  • S. Riley

Principal Investigators

  • R. Al-Lehebi

  • S. Gurupatham

  • E. Grbac

  • M. B. Stanbrook

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • Pulmonary and Critical Care Medicine, King Fahad Medical City, Riyadh, Saudi Arabia,

  • University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Eosinophil

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved